ARTICLE
9 September 2014

Enforcement Updates - Issue 13, September 2014

JD
Jones Day

Contributor

Jones Day is a global law firm with more than 2,500 lawyers across five continents. The Firm is distinguished by a singular tradition of client service; the mutual commitment to, and the seamless collaboration of, a true partnership; formidable legal talent across multiple disciplines and jurisdictions; and shared professional values that focus on client needs.
Recent food recalls involved microbial contaminations, undeclared ingredients, and one product with questionable packaging seals.
United States Food, Drugs, Healthcare, Life Sciences

Recent Product Recalls

Recent food recalls involved microbial contaminations, undeclared ingredients, and one product with questionable packaging seals. One manufacturer recalled multiple brands of peanut and almond butters due to potential Salmonella contamination. A brand of parmesan cheese was also recalled for Salmonella concerns, while another cheese product was called back because a supplier did not properly store ingredients according to the manufacturer's temperature standards. Two companies also recalled breaded chicken products and chicken Caesar salad kits for possible Listeria contamination.

Additionally, manufacturers recalled several food products because the products contained undeclared allergens. Another company recalled certain lots of two canned vegetable products because the cans may not have been properly sealed to ensure safety.

As FDA continues to test dietary supplements for illegal ingredients, another appetite-control supplement was recalled last month for containing DMMA.

Finally, two adult dog food products were recalled for presence of foreign materials.

For a complete list of product recalls, click here for FDA-regulated products, and here for USDA-regulated products.

Recent Warning Letters

Recent warnings since the last Update include notices to five dairy farms for selling cattle adulterated with illegal drug residue and a warning letter to a lobster-processing facility for failing to comply with hazard analysis and critical control points regulations.

FDA also posted warning letters to several dietary supplement manufacturers. The agency cited a private label manufacturer for violating current good manufacturing practice requirements and marketing misbranded products, in part because the labels of several products lacked the required term "dietary supplement." FDA warned two other dietary supplement manufacturers for marketing unapproved drugs because their products promote therapeutic claims.

Click here for FDA's Warning Letters Home page (scroll down for listing of recently posted Warning Letters).

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More